Amylyx Pharmaceuticals (AMLX) Other Operating Expenses (2022 - 2024)
Amylyx Pharmaceuticals (AMLX) posted quarterly Other Operating Expenses of $37.0 million for Q3 2024, up 609.31% year-over-year from $5.2 million in Q4 2023, and up 398.95% quarter-over-quarter from $7.4 million in Q2 2024.
Amylyx Pharmaceuticals (AMLX) Other Operating Expenses (2022 - 2024) Analysis & Trends
Amylyx Pharmaceuticals' Other Operating Expenses history runs 3 years deep, the most recent figure standing at $37.0 million for Q3 2024.
- In Q3 2024, Other Operating Expenses rose 609.31% year-over-year to $37.0 million; the TTM figure through Jun 2025 stood at $37.0 million (down 73.26% YoY), while the FY2024 annual figure was $160.8 million, up 532.19% from the prior year.
- Other Operating Expenses for Q3 2024 stood at $37.0 million, up from $7.4 million in the prior quarter.
- The five-year high for Other Operating Expenses was $116.4 million in Q1 2024, with the low at $172000.0 in Q3 2022.
- The 3-year median for Other Operating Expenses is $5.6 million (2023), against an average of $21.0 million.
- The sharpest annual moves came in 2023 and 2024: Other Operating Expenses surged 2933.72% in 2023, then jumped 32.94% in 2024.
- Amylyx Pharmaceuticals' Other Operating Expenses stood at $2.8 million in 2022, then surged by 231.8% to $9.4 million in 2023, then surged by 295.43% to $37.0 million in 2024.
- Business Quant data shows AMLX's Other Operating Expenses at $37.0 million in Q3 2024, $7.4 million in Q2 2024, and $116.4 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 86.50 Bn | 85.53 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.71 Bn | 39.05 Bn | 2.15 Bn |
| 3 | Zoetis | 30.86 Bn | 29.18 Bn | 1.80 Bn |
| 4 | Takeda Pharmaceutical | 28.50 Bn | 22.70 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.06 Bn | 19.40 Bn | 683.80 Mn |
| 6 | Viatris | 18.84 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Vireo Growth | 11.86 Bn | 11.71 Bn | 59.30 Mn |
| 9 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn |
| 10 | Amylyx Pharmaceuticals | 3.91 Bn | 3.91 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 37.01 Mn |
| Jun 30, 2024 | 7.42 Mn |
| Mar 31, 2024 | 116.41 Mn |
| Dec 31, 2023 | 9.36 Mn |
| Sep 30, 2023 | 5.22 Mn |
| Jun 30, 2023 | 5.58 Mn |
| Mar 31, 2023 | 5.28 Mn |
| Dec 31, 2022 | 2.82 Mn |
| Sep 30, 2022 | 172,000.00 |